|
|
|
Insider
Information: |
Rubin Paul D |
Relationship: |
Sr. VP Clinical Dev. &... |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
326,601 |
|
Indirect Shares
|
13,422 |
|
|
Direct
Value |
$7,831,892 |
|
|
Indirect Value
|
$321,860 |
|
|
Total
Shares |
340,023 |
|
|
Total
Value |
$8,153,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
XOMA Corporation |
XOMA |
Sr. VP Clinical Dev. &... |
2016-03-22 |
326,601 |
2016-03-22 |
13,422 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2012-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,887 |
0 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,205 |
20,241 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-04-18 |
4 |
AS |
$0.00 |
$0 |
D/D |
(6,000) |
8,749 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
8,201 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-06-18 |
4 |
AS |
$0.00 |
$0 |
D/D |
(6,000) |
3,534 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
30,849 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
68,793 |
72,021 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
85,386 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2014-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
98,769 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,900 |
142,398 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2015-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,346 |
172,744 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,666 |
124,133 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2015-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
149,093 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
198,330 |
338,654 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2016-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,141 |
350,795 |
0 |
- |
|
XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
|
2011-09-30 |
4 |
OE |
$1.66 |
$1,699 |
D/D |
1,022 |
1,022 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-10-18 |
4 |
OE |
$2.36 |
$1,761 |
D/D |
746 |
9,534 |
0 |
- |
|
XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
|
2011-12-30 |
5 |
A |
$1.09 |
$1,787 |
D/D |
1,636 |
2,658 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-05-20 |
4 |
OE |
$2.36 |
$1,853 |
D/D |
785 |
9,534 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2012-06-29 |
4 |
OE |
$2.83 |
$1,871 |
D/D |
661 |
661 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2012-12-31 |
4 |
OE |
$2.28 |
$1,899 |
D/D |
833 |
2,036 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2012-09-28 |
4 |
OE |
$3.51 |
$1,900 |
D/D |
542 |
1,203 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-06-28 |
4 |
OE |
$3.45 |
$1,955 |
D/D |
567 |
4,101 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-12-31 |
5 |
A |
$6.39 |
$1,956 |
D/D |
306 |
6,309 |
0 |
- |
|
XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
|
2013-09-30 |
4 |
A |
$4.27 |
$1,958 |
D/D |
459 |
8,788 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|